Latest Paclitaxel Stories
Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the
Additional Independent Review Board Approvals Expected for Phase 2 Trial (Study 202) SAN DIEGO, July 22, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.
HARBIN, China, July 15, 2014 /PRNewswire/ -- Yew Bio-Pharm Group, Inc.
Innovative Technology Strengthens Company's Leading Portfolio of Solutions for Peripheral Vascular Disease MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Demonstrating its continued
CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
SAN DIEGO, June 25, 2014 /PRNewswire/ -- Concortis Biosystems, Inc.
SAN DIEGO, June 20, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Health Canada has reinstated Biolyse Pharma’s Establishment Licence (EL) after sending in a team of inspectors to look at manufacturing within the St.Catharines based Pharmaceutical.
Transparency Market Research added a new report "Drug Eluting Balloons Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its report store.